期刊文献+

二次电切阳性发现在T1期膀胱癌中的临床意义 被引量:10

Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer
原文传递
导出
摘要 目的探索T1期膀胱癌二次电切阳性率的影响因素及二次电切阳性发现对疾病预后的影响。方法收集北京大学第一医院泌尿外科室从2008至2015年因T1期膀胱癌行二次经尿道膀胱肿瘤电切术(re-TURBT)的患者共计72例。分析re-TURBT阳性率的影响因素,并对re-TURBT术后患者进行随访,比较re-TURBT阳性或阴性发现对预后的影响。结果re-TURBT阳性率为33.3%。T1期膀胱癌re-TURBT阳性与肿瘤大小相关(P〈0.05),肿瘤直径较大(/〉4cm)的患者二次电切阳性的可能大,而与肿瘤分级和数目无关。re-TURBT术后随访65例。阳性组3个月内复发率为25%,阴性组3个月内无复发病例,两者差异有统计学意义(P〈0.001)。阳性组和阴性组的肿瘤总复发率、中位无复发生存时间、肿瘤进展率、切除膀胱率、肿瘤特异性死亡率无显著性差异。结论对T1期膀胱癌来说较大体积的肿瘤预示着二次电切的阳性率较高,二次电切结果与肿瘤早期复发相关。 Objective To investigate the predictors of residual tumors at repeat transurethral resection of bladder tumors (re-TURBT) for the patients with T1 bladder cancer and evaluate the effect of the residual tumors on the prognosis of the disease. Methods We reviewed the clinical data of the patients with T1 bladder cancer who underwent re-TURBT from 2008 to 2015 in our department. Seventy-two patients received re-TURBT 2 - 6 weeks after the initial TURBT. A total of 65 patients were followed up, and we recorded the events of tumor recurrence, tumor progression, radical cystectomy and cancer specific death. The influencing factors of re-TURBT positive rate were analyzed. The effects of re-TURBT positive or negative findings on the prognosiswere compared. Results 33.3% of the patients who received re-TURBT had residual tumours. Re-TURBT positive in T1 bladder cancer has significant correlation with tumor size ( P 〈 0. 05 ). Residual tumors tended to be detected in patients with larger tumors ( diameter ≥ 4 cm) but might have no relationship with tumor grade or tumor number. The recurrence rate within 3 month ofthe patients with residual tumours at re-TURBT was 25% (5/20), while there were no patients suffering recurrence who had no residual turnouts at re-TURBT, which had a significant difference ( P 〈 0. 001 ). However, the overall recurrence rate, progression rate, rate of radical cystectomy and cancer specific mortality showed no significant difference between the two groups ( 45% vs 40% , P = 0.71 ; 10% vs 6.7%, P=0.64; 5% vs 8.9%, P=0.59; 5% vs2.2%, P=0.55). Conclusions For the patients with T1 bladder cancer, larger tumors could be a predictor for residual tumors at re-TURBT. The presence of residual tumors is associated with early recurrence.
出处 《中华医学杂志》 CAS CSCD 北大核心 2016年第14期1124-1127,共4页 National Medical Journal of China
关键词 膀胱肿瘤 肿瘤残余 Urinary Bladder neoplasms Neoplasm residual
  • 相关文献

参考文献11

  • 1Babjuk M,Burger M,Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder : update 2013[J] . Eur Urol, 2013 , 64 ( 4 ) : 639-653. DOI: 10. 1016/j. eururo. 2013. 06. 003. 被引量:1
  • 2Jakse G, Algaba F, Malmstrom PU, et al. A second-look TUR inT1 transitional cell carcinoma: why? [ J ]. Eur Urol, 2004,45(5) :539-546. DOI: 10. 1016/j. eururo. 2003. 12.016. 被引量:1
  • 3Herr HW,Donat SM,Daibagni G. Can restaging transurethralresection of T1 bladder cancer select patients for immediatecystectomy? [J]. J Urol, 2007,177 (1 ) :75-79. DOI: 10. 1016/j. juro. 2006. 08. 070. 被引量:1
  • 4Divrik RT,Sahin AF, Yildirim U, et al. Impact of routine secondtransurethral resection on the long-term outcome of patients withnewly diagnosed pTl urothelial carcinoma with respect torecurrence,progression rate,and disease-specific survival : aprospective randomised clinical trial[ J]. Eur Urol, 2010,58(2):185-190. DOI: 10. 1016/j. eururo. 2010. 03. 007. 被引量:1
  • 5Yucel M, Hatipoglu NK, Atakanli C, et al. Is repeattransurethral resection effective and necessary in patients with T1bladder carcinoma? [J]. Urol Int, 2010,85(3) :276-280. DOI:10. 1159/000316073. 被引量:1
  • 6Orsola A, Cecchini L, Ravent6s CX, et al. Risk factors forpositive findings in patients with high-grade T1 bladder cancertreated with transurethral resection of bladder tumour (TUR) andbacille Calmette-Gu6rin therapy and the decision for a repeat TUR[J]. BJU Int, 2010,105(2):202-207. DOI: 10. 1111/j. 1464-410X. 2009. 08694. x. 被引量:1
  • 7邓建华,李汉忠,张玉石.非肌层浸润性膀胱癌进展风险研究现状[J].中华医学杂志,2014,94(22):1758-1759. 被引量:17
  • 8SOer E,Ozcan C,Baltacl S, et ai. Time between first and secondtransurethral resection of bladder tumors in patients with high-grade T1 tumors : is it a risk factor for residual tumor detection?.. Urol Int, 2013, 91 (2): 182-186. DOI: 10. 1159/000350512. 被引量:1
  • 9Zurkirchen MA,Sulser T,Gaspert A,et al. Second transurethralresection of superficial transitional cell carcinoma of the bladder: amust even for experienced urologists[ J]. Urol Int, 2004,72(2):99-102. DOI: 10. 1159/000075961. 被引量:1
  • 10张超,张连华,薄隽杰,沙建军,吕坚伟,冷静,刘东明,黄翼然.首诊T1期膀胱尿路上皮癌患者二次经尿道膀胱肿瘤电切除术的临床意义[J].中华老年医学杂志,2011,30(4):299-301. 被引量:3

二级参考文献39

  • 1张薇,项永兵,刘振伟,方茹蓉,阮志贤,孙璐,高立峰,金凡,高玉堂.1973-1999年上海市区老年人恶性肿瘤发病趋势分析[J].中华老年医学杂志,2005,24(9):701-704. 被引量:85
  • 2周梁,史本涛,王盛兴,罗勇,杨林,张林琳,王新阳,贺大林.表浅性与浸润性膀胱癌基因表达谱的比较[J].中华医学杂志,2007,87(12):798-801. 被引量:4
  • 3Divrik RT,Sahin AF,Yildirim U,et al.Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence,progression rate,and disease-specific survival:a prospective randomized clinical trial.Eur Urol,2010,58:185-190. 被引量:1
  • 4Grimm MO,Steinhoff C,Simon X,et al.Effect of routine repeat transurethral resection for superficial bladder cancer:a long-term observational study.J Urol,2003,170:433-437. 被引量:1
  • 5Herr HW.Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to Bacillus Calmette-Guerin therapy.J Urol,2005,174:2134-2137. 被引量:1
  • 6Clark PE.Bladder cancer.Curr Opin Oncol,2007,19:241-247. 被引量:1
  • 7Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108. 被引量:1
  • 8Witjes JA,Douglass J.The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.Nat Clin Pract Urol,2007,4:542-549. 被引量:1
  • 9Eble JN,Sauter G,Epstein JI,et al.World health organization classification of tumors.Tumors of the urinary system and genital organs.Lyon:IARC Press.2006:90-109. 被引量:1
  • 10Babjuk M.Second resection for non-muscle-invasive bladder carcinoma:current role and future perspectives.Eur Urol,2010,58:191-192. 被引量:1

共引文献18

同被引文献79

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部